Harper's Biochemistry Chapter 17 - Gluconeogenesis & the Control of Blood Glucose.PDF

Full Transcript

C H A P T E R Gluconeogenesis & the Control of Blood Glucose Owen P. McGuinness, PhD 19 OBJ E C TI VE S Explain the importance of gluconeogenesis in glu...

C H A P T E R Gluconeogenesis & the Control of Blood Glucose Owen P. McGuinness, PhD 19 OBJ E C TI VE S Explain the importance of gluconeogenesis in glucose homeostasis. Describe the pathway of gluconeogenesis, how irreversible enzymes of After studying this chapter, glycolysis are bypassed, and how glycolysis and gluconeogenesis are regulated you should be able to: reciprocally. Explain how plasma glucose concentration is maintained within narrow limits in the fed and fasting states. BIOMEDICAL IMPORTANCE tissue ipoysis reeases gycero. Skeeta musce reeases ac- tate an guconeogenic amino acis. As the fast is extene Guconeogenesis is the process of synthesizing gucose from gycero an amino acis provie an increasing roe in sup- noncarbohyrate precursors. The major substrates are the pying carbon for guconeogenesis. One might think that as a gucogenic amino acis (see Chapter 29), actate, gycero, an fast progresses guconeogenesis increases even more. In fact, propionate. Liver an kiney are the major guconeogenic tissues. it oes not. This is because the gucose emans of periphera The iver is the primary guconeogenic organ. Whie the rena tissues ecrease incuing the brain. This preserves the vita cortex of the kiney may contribute about 10% of whoe boy protein stores. In the fe state guconeogenic suppy oes not guconeogenesis after a short-term fast (18-24 h), the kiney is ecrease, in fact it is eevate. The mix of carbon sources is not a net source of gucose. This is because the rena meua is ifferent. Gycero suppy ecreases because of a ecrease in a consumer of gucose. It is ony with ong-term fasting (~7 ays) ipoysis. Lactate suppy oes not ecrease primariy because that the kiney can suppy net gucose carbon to contribute of the high rates of gycoysis in skeeta musce. Amino aci to gucose homeostasis. The key guconeogenic enzymes are suppy increases as amino acis erive from ietary protein expresse in the sma intestine. Propionate arising from intes- are irecty eivere into the porta vein. During exercise actate tina bacteria fermentation of carbohyrates is a substrate for suppy from working musce heps support the increase gu- guconeogenesis in enterocytes. The intestine is not a net con- coneogenic eman of exercise. sumer of actate an aanine or gycero, the major substrates The transport an uptake of amino acis, gycero, an for guconeogenesis. It is a consumer of gucose in the fasting actate are reguate ifferenty. The iver is extremey effi- state. Thus, any gucose synthesis that occurs ocay is ikey cient at taking up gycero. Greater than 60% of gycero metaboize ocay. eivere to the iver is remove on first pass. This frac- The rate of hepatic guconeogenesis is etermine by tion remains constant in response to increase or ecrease four factors: (1) the avaiabiity of guconeogenic substrates, in insuin, gucagon, an epinephrine which are impor- (2) the capacity of the iver to take up guconeogenic sub- tant reguators of guconeogenesis. In contrast amino aci strates, (3) the quantity an activity of the guconeogenic remova is very sensitive to gucagon an to a esser extent enzymes, an (4) the oxiative capacity of the iver to not ony insuin. Gucagon is a potent stimuator of the transport suppy the energy to support the energy requiring process of of gucogenic amino acis by the iver. About 20% of these guconeogenesis but metaboize the nitrogen from the guco- amino acis are remove on first pass; first pass extraction genic amino acis (Ureagenesis; see Chapter 28). can increase to more than 60% in the presence of an increase Throughout the 24-hour feeing fasting cyce guconeo- in gucagon. Insuin can stimuate amino aci transport but genic precursors are avaiabe. In the fasting state aipose the response is much smaer than that of gucagon. Lactate uptake by the iver is compex because the iver can prouce This was aapte from the 30th eition by Davi A. Bener, PhD & actate uring high rates of gycogen breakown. However, Peter A. Mayes, PhD, DSc in the fasting state the primary river is the avaiabiity of 180 CHAPTER 19 Gluconeogenesis & the Control of Blood Glucose 181 actate. When actate is increase aong with increases in Pyruvate & Phosphoenolpyruvate gucagon the iver can become an efficient consumer of ac- Reversa of the reaction catayze by pyruvate kinase in gyco- tate, supporting the guconeogenic response, for exampe, ysis invoves two enothermic reactions. Mitochonria pyru- as is seen in exercise. vate carboxylase catayzes the carboxyation of pyruvate to In this chapter we wi tak about the guconeogenic path- oxaoacetate, an ATP-requiring reaction in which the vitamin ways an the sites of reguation. These sites are ceary impor- biotin is the coenzyme. Biotin bins CO2 from bicarbonate as tant in fine-tuning how substrates enter an fow through the carboxybiotin prior to the aition of the CO2 to pyruvate (see guconeogenic pathway. However, substrate suppy an sub- Figure 44–14). The resutant oxaoacetate is reuce to maate, strate transport can overrie this reguation by mass action. exporte from the mitochonrion into the cytoso an then For exampe, one might expect that guconeogenesis ecreases oxiize back to oxaoacetate. A secon enzyme, phospho- after a mea as insuin goes up an gucagon eve fas, which enolpyruvate carboxykinase, catayzes the ecarboxyation shou inhibit the guconeogenic enzymes. However, what is an phosphoryation of oxaoacetate to phosphoenopyru- foun is guconeogenesis persists. Deivery an transport of vate using GTP as the phosphate onor. In iver an kiney, substrates are sustaine offsetting the ownreguation of the the reaction of succinate thiokinase in the citric aci cyce enzymes. However, the iver oes not reease the guconeo- (see Chapter 16) prouces GTP (rather than ATP as in other genic-erive carbon; it iverts it into gycogen to augment tissues), an this GTP is use for the reaction of phosphoeno- mea-erive gycogen synthesis (inirect gycogen synthesis; pyruvate carboxykinase. This provies a ink between citric see Chapter 18). aci cyce activity an guconeogenesis, to prevent excessive In isease states associate with hypergycemia (eg, remova (ie, anaperosis an cataperosis have to be equa) of infection an iabetes) guconeogenesis is inappropriatey oxaoacetate for guconeogenesis, which wou impair citric increase. In critically ill patients in response to injury aci cyce activity. an infection guconeogenic suppy is very high (eevate actate, increase ipoysis, increase protein cataboism). Fructose 1,6-Bisphosphate Combine with the unerying insuin resistance an high & Fructose-6-Phosphate gucagon eves it rives guconeogenesis an inuces hyperglycemia, which is associate with poor outcomes. The conversion of fructose 1,6-bisphosphate to fructose- In insuin eficiency (iabetic ketoaciosis) as is seen in 6-phosphate, for the reversa of gycoysis, is catayze by Type 1 iabetes (see Chapter 14), in the absence of insuin fructose 1,6-bisphosphatase. Its presence etermines whether an very high gucagon the unoppose ipoysis an pro- a tissue is capabe of synthesizing gucose (or gycogen) not ony tein cataboism ampifies the hypergycemia. Hypergyce- from pyruvate but aso from triose phosphates (eg, gycero). mia eas to changes in osmoaity of boy fuis, impaire It is present in iver, kiney, an skeeta musce, but is probaby boo fow, intraceuar aciosis, an increase superoxie absent from heart an smooth musce. raica prouction (see Chapter 45), resuting in erange enotheia an immune system function an impaire Glucose-6-Phosphate & Glucose boo coaguation. The conversion of gucose-6-phosphate to gucose is cata- With iver faiure guconeogenesis is impaire an hypogy- yze by glucose-6-phosphatase. It is present in iver an cemia eveops espite the fact that substrate suppy is high an kiney (rena cortex), but absent from musce, which, there- there is severe insuin resistance an very high gucagon eves. In fore, cannot export gucose erive from gycogen into the this case, the inabiity to support energy prouction in the iver boostream. (impaire citric aci cyce fux an ureagenesis; see Chapter 16) starves the guconeogenic pathway of the energy require to sup- Glucose-1-Phosphate & Glycogen port the synthesis of gucose. The breakown of gycogen to gucose-1-phosphate is cata- yze by phosphoryase. Gycogen synthesis invoves a iffer- ent pathway via uriine iphosphate gucose an glycogen GLUCONEOGENESIS INVOLVES synthase (see Figure 18–1). GLYCOLYSIS, THE CITRIC ACID The reationships between guconeogenesis an the gyco- CYCLE, PLUS SOME SPECIAL ytic pathway are shown in Figure 19–1. After transamination or eamination, gucogenic amino acis yie either pyruvate REACTIONS or intermeiates of the citric aci cyce. Therefore, the reac- Thermodynamic Barriers Prevent a tions escribe earier can account for the conversion of both actate an gucogenic amino acis to gucose or gycogen. Simple Reversal of Glycolysis Propionate is a major precursor of gucose in ruminants; Three nonequiibrium reactions in gycoysis (see Chapter 17), it enters guconeogenesis via the citric aci cyce. After catayze by hexokinase, phosphofructokinase, an pyruvate esterification with CoA, propiony-CoA is carboxyate to kinase, prevent simpe reversa of gycoysis for gucose syn- d-methymaony-CoA, catayze bypropionyl-CoA carboxylase, thesis (Figure 19–1). They are circumvente as foows. a biotin-epenent enzyme (Figure 19–2). Methylmalonyl-CoA 182 SECTION IV Metabolism of Carbohydrates FIGURE 19–1 Major pathways and regulation of gluconeogenesis and glycolysis in the liver. Entry points of glucogenic amino acids after transamination are indicated by arrows extended from circles (see also Figure 16–4). The key gluconeogenic enzymes are shown in double- bordered boxes. The ATP required for gluconeogenesis is supplied by the oxidation of fatty acids. Propionate is important only in ruminants. Arrows with wavy shafts signify allosteric effects; dash-shafted arrows, covalent modification by reversible phosphorylation. High concentrations of alanine act as a “gluconeogenic signal” by inhibiting glycolysis at the pyruvate kinase step. racemase catayzes the conversion of d-methymaony-CoA to the sie chain of choestero, an is a (reativey minor) substrate l-methymaony-CoA, which then unergoes isomerization for guconeogenesis. Methymaony-CoA mutase is a vitamin to succiny-CoA catayze by methylmalonyl-CoA mutase. In B12 -epenent enzyme, an in B12 eficiency, methymaonic nonruminants, incuing human beings, propionate arises from aci is excrete in the urine (methylmalonic aciduria). the β-oxiation of o-chain fatty acis that occur in ruminant Gycero is reease from aipose tissue as a resut of ipis (see Chapter 22), as we as the oxiation of isoeucine an ipoysis of ipoprotein triacygycero in the fe state; it may CHAPTER 19 Gluconeogenesis & the Control of Blood Glucose 183 CoA SH Acyl-CoA CO2 + H2O Propionyl-CoA CH3 synthetase CH3 carboxylase CH3 CH2 CH2 H C COO– Mg2+ Biotin COO– CO S CoA CO S CoA ATP AMP + PPi ATP ADP + Pi Propionate Propionyl-CoA D-Methyl- malonyl-CoA Methylmalonyl-CoA racemase COO– Methylmalonyl- CoA mutase CH3 CH2 Intermediates – OOC C H of citric acid cycle CH2 B12 coenzyme CO S CoA CO S CoA L-Methyl- Succinyl-CoA malonyl-CoA FIGURE 19–2 Metabolism of propionate. be use for reesterification of free fatty acis to triacygycero, antagonizes the effect of the gucocorticois an gucagon- or may be a substrate for guconeogenesis in the iver. In the stimuate cAMP, which inuce synthesis of the key enzymes fasting state, gycero reease from ipoysis of aipose tissue of guconeogenesis. triacygycero is use as a substrate for guconeogenesis in the iver an kineys. Covalent Modification by Reversible Phosphorylation Is Rapid GLYCOLYSIS & Glucagon an epinephrine, hormones that are responsive GLUCONEOGENESIS SHARE to a ecrease in boo gucose, inhibit gycoysis an stimu- ate guconeogenesis in the iver by increasing the concentra- THE SAME PATHWAY BUT IN tion of cAMP. This in turn activates cAMP-epenent protein OPPOSITE DIRECTIONS, & ARE kinase, eaing to the phosphoryation an inactivation of RECIPROCALLY REGULATED pyruvate kinase. They aso affect the concentration of fructose 2,6-bisphosphate an therefore gycoysis an guconeogen- Changes in the avaiabiity of substrates are responsibe for esis, as escribe ater. In aition, as mentione gucagon is a most changes in metaboism either irecty or inirecty act- potent stimuator of amino aci transport. ing via changes in hormone secretion. Three mechanisms are responsibe for reguating the activity of enzymes concerne in carbohyrate metaboism: (1) changes in the rate of enzyme Allosteric Modification Is Instantaneous synthesis, (2) covaent moification by reversibe phosphory- In guconeogenesis, pyruvate carboxyase, which catayzes the ation, an (3) aosteric effects. synthesis of oxaoacetate from pyruvate, requires acety-CoA as an allosteric activator. The aition of acety-CoA resuts Induction & Repression of Key Enzymes in a change in the tertiary structure of the protein, ower- ing the Km for bicarbonate. This means that as acety-CoA is Require Several Hours forme from pyruvate, it automaticay ensures the provision The changes in enzyme activity in the iver that occur uner of oxaoacetate by activating pyruvate carboxyase. The acti- various metaboic conitions are iste in Table 19–1. The vation of pyruvate carboxyase an the reciproca inhibition enzymes invove catayze physioogicay irreversibe non- of pyruvate ehyrogenase by acety-CoA erive from the equiibrium reactions. The effects are generay reinforce oxiation of fatty acis expain the action of fatty aci oxia- because the activity of the enzymes catayzing the reactions tion in sparing the oxiation of pyruvate (an hence gucose) in the opposite irection varies reciprocay (see Figure 19–1). an stimuating guconeogenesis. The reciproca reation- The enzymes invove in the utiization of gucose (ie, those of ship between these two enzymes aters the metaboic fate of gycoysis an ipogenesis) become more active when gucose pyruvate as the tissue changes from carbohyrate oxiation avaiabiity is high such as after a mea, an uner these con- (gycoysis) to guconeogenesis uring the transition from the itions the enzymes of guconeogenesis have reativey ow fe to fasting state (see Figure 19–1). A major roe of fatty aci activity. Insuin, secrete in response to increase boo gucose, oxiation in promoting guconeogenesis is to suppy the ATP enhances the synthesis of the key enzymes in gycoysis. It aso that is require for gucose synthesis. 184 SECTION IV Metabolism of Carbohydrates TABLE 19–1 Regulatory & Adaptive Enzymes Associated With Carbohydrate Metabolism Activity in Fasting Carbohydrate and Feeding Diabetes Inducer Repressor Activator Inhibitor Glycogenolysis, glycolysis, and pyruvate oxidation Glycogen synthase ↑ ↓ Insulin, glucose-6- Glucagon phosphate Hexokinase Glucose-6- phosphate Glucokinase ↑ ↓ Insulin Glucagon Phosphofructokinase-1 ↑ ↓ Insulin Glucagon 5′ AMP, fructose- Citrate, ATP, 6-phosphate, glucagon fructose 2,6-bisphosphate, Pi Pyruvate kinase ↑ ↓ Insulin, fructose Glucagon Fructose ATP, alanine, 1,6-bisphosphate, glucagon, insulin norepinephrine Pyruvate dehydrogenase ↑ ↓ CoA, NAD+, insulin, Acetyl-CoA, ADP, pyruvate NADH, ATP (fatty acids, ketone bodies) Gluconeogenesis Pyruvate carboxylase ↓ ↑ Glucocorticoids, Insulin Acetyl-CoA ADP glucagon, epinephrine Phosphoenolpyruvate ↓ ↑ Glucocorticoids, Insulin carboxykinase glucagon, epinephrine Glucose-6-phosphatase ↓ ↑ Glucocorticoids, Insulin glucagon, epinephrine Phosphofructokinase (phosphofructokinase-1) occupies activates gycogen phosphoryase, so increasing gycogenoysis. a key position in reguating gycoysis an is aso subject to A consequence of the inhibition of phosphofructokinase-1 feeback contro. It is inhibite by citrate an by norma intra- by ATP is an accumuation of gucose-6-phosphate, which in ceuar concentrations of ATP an is activate by 5′ AMP. At the turn inhibits further uptake of gucose in extrahepatic tissues norma intraceuar [ATP] the enzyme is about 90% inhibite; by inhibition of hexokinase. Remember gucokinase, which is this inhibition is reverse by 5′AMP (Figure 19–3). present in the iver, is not inhibite by gucose-6-phosphate 5′ AMP acts as an inicator of the energy status of the ce. thus aowing for high rates of gucose entry an iversion to The presence of adenylyl kinase in iver an many other tis- gycogen eposition at the same time aow for guconeogene- sues aows rapi equiibration of the reaction sis-erive carbon to be iverte to gycogen as we. 2ADP ↔ ATP + 5′ AMP Fructose 2,6-Bisphosphate Plays a Thus, when ATP is use in energy-requiring processes, resuting in the formation of ADP, [AMP] increases. A rea- Unique Role in the Regulation of tivey sma ecrease in [ATP] causes a severa fo increase in Glycolysis & Gluconeogenesis in Liver [AMP], so that [AMP] acts as a metaboic ampifier of a sma The most potent positive aosteric activator of phospho- change in [ATP], an hence a sensitive signa of the energy fructokinase-1 an inhibitor of fructose 1,6-bisphosphatase in state of the ce. The activity of phosphofructokinase-1 is thus iver is fructose 2,6-bisphosphate. It reieves inhibition of phos- reguate in response to the energy status of the ce to con- phofructokinase-1 by ATP an increases the affinity for fructose- tro the quantity of carbohyrate unergoing gycoysis prior 6-phosphate. It inhibits fructose 1,6-bisphosphatase by increasing to its entry into the citric aci cyce. At the same time, AMP the Km for fructose 1,6-bisphosphate. Its concentration is uner CHAPTER 19 Gluconeogenesis & the Control of Blood Glucose 185 + 5AMP Relative activity No AMP 0 1 2 3 4 5 ATP (mmol /L) FIGURE 19–3 The inhibition of phosphofructokinase-1 by ATP and relief of inhibition by AMP. The yellow bar shows the normal range of the intracellular concentration of ATP. both substrate (aosteric) an hormona contro (covaent It wou seem obvious that these opposing enzymes are regu- moification) (Figure 19–4). ate in such a way that when those invove in gycoysis are Fructose 2,6-bisphosphate is forme by phosphoryation active, those invove in guconeogenesis are reativey inac- of fructose-6-phosphate by phosphofructokinase-2. The same tive, since otherwise there wou be cycing between phos- enzyme protein is aso responsibe for its breakown, since it phoryate an nonphosphoryate intermeiates, with net has fructose 2,6-bisphosphatase activity. This bifunctional hyroysis of ATP. In fact in the iver futie cycing of carbon enzyme is uner the aosteric contro of fructose-6-phosphate, (1-2%) is present at a ow rate. The avantage is by having both which stimuates the kinase an inhibits the phosphatase. pathways the iver is aowe to rapiy transition from the Hence, when there is an abunant suppy of gucose, the con- fe, faste, or exercising state. In musce both phosphofruc- centration of fructose 2,6-bisphosphate increases, stimuating tokinase an fructose 1,6-bisphosphatase have some activity gycoysis by activating phosphofructokinase-1 an inhibit- at a times, so that there is inee even more wastefu sub- ing fructose 1,6-bisphosphatase. In the fasting state, gucagon strate cycing. This permits the very rapi increase in the rate stimuates the prouction of cAMP, activating cAMP-epenent of gycoysis necessary for musce contraction. At rest the rate protein kinase, which in turn inactivates phosphofructokinase-2 of phosphofructokinase activity is some 10-fo higher than an activates fructose 2,6-bisphosphatase by phosphorya- that of fructose 1,6-bisphosphatase; in anticipation of musce tion. Hence, guconeogenesis is stimuate by a ecrease in the contraction, the activity of both enzymes increases, fructose concentration of fructose 2,6-bisphosphate, which inactivates 1,6-bisphosphatase 10 times more than phosphofructokinase, phosphofructokinase-1 an reieves the inhibition of fructose maintaining the same net rate of gycoysis. At the start of musce 1,6-bisphosphatase. Xyuose 5-phosphate, an intermeiate of the contraction, the activity of phosphofructokinase increases fur- pentose phosphate pathway (see Chapter 20) activates the protein ther, an that of fructose 1,6-bisphosphatase fas, so increasing phosphatase that ephosphoryates the bifunctiona enzyme, so the net rate of gycoysis (an hence ATP formation) as much as increasing the formation of fructose 2,6-bisphosphate an increas- a 1000-fo. ing the rate of gycoysis. This eas to increase fux through gy- coysis an the pentose phosphate pathway an increase fatty aci synthesis (see Chapter 23). THE BLOOD CONCENTRATION OF GLUCOSE IS REGULATED WITHIN Substrate (Futile) Cycles Allow Fine NARROW LIMITS Tuning & Rapid Response In the postabsorptive state, the concentration of boo gucose The contro points in gycoysis an gycogen metaboism is maintaine between 4.5 an 5.5 mmo/L. After the inges- invove a cyce of phosphoryation an ephosphorya- tion of a carbohyrate mea, it may rise to 6.5 to 7.2 mmo/L, tion catayze by gucokinase an gucose-6-phosphatase; an in starvation, it may fa to 3.3 to 3.9 mmo/L. A suen phosphofructokinase-1 an fructose 1,6-bisphosphatase; pyru- ecrease in boo gucose (eg, in response to insuin overose) vate kinase, pyruvate carboxyase, an phosphoenopyruvate causes convusions, because of the epenence of the brain carboxykinase; an gycogen synthase an phosphoryase. on a suppy of gucose. However, much ower concentrations 186 SECTION IV Metabolism of Carbohydrates Glycogen Gucose is forme from two groups of compouns that glucose unergo guconeogenesis (see Figures 16–4 an 19–1): (1) those that invove a irect net conversion to gucose, incuing most Fructose-6-phosphate amino acids an propionate an (2) those that are the pro- Glucagon ucts of the metaboism of gucose in tissues. Thus, lactate, forme by gycoysis in skeeta musce an erythrocytes, is Pi cAMP transporte to the iver an kiney where it reforms gucose, which again becomes avaiabe via the circuation for oxia- cAMP-dependent tion in the tissues. This process is known as the Cori cycle, or protein kinase the lactic acid cycle (Figure 19–5). ADP In the fasting state, there is a consierabe output of aanine ATP from skeeta musce, far in excess of the amount in the musce proteins that are being cataboize. It is forme by transami- Active Inactive Gluconeogenesis F-2,6-pase F-2,6-pase nation of pyruvate prouce by gycoysis of musce gycogen, Glycolysis P Inactive Active an is exporte to the iver, where, after transamination back PFK-2 PFK-2 to pyruvate, it is a substrate for guconeogenesis. This glucose- alanine cycle (see Figure 19–5) provies an inirect way of uti- H2 O Pi izing musce gycogen to maintain boo gucose in the fasting state. The gycero reease by aipose tissue is another source Protein of guconeogenic carbon aong with the actate reease by musce. phosphatase-2 ADP Citrate The ATP require for the hepatic synthesis of gucose from Fructose 2,6 -bisphosphate pyruvate (or gycero) is forme by the oxiation of fatty acis Pi ATP erive from aipose tissue ipoysis. Gucose is aso forme F-1,6-pase PFK-1 from iver gycogen by gycogenoysis (see Chapter 18). H2O ADP Metabolic & Hormonal Mechanisms Fructose 1,6-bisphosphate Regulate the Concentration of Blood Glucose Pyruvate The maintenance of a stabe boo gucose concentration is one of the most finey reguate of a homeostatic mecha- FIGURE 19–4 Control of glycolysis and gluconeogenesis nisms, invoving the iver, extrahepatic tissues, an severa in the liver by fructose 2,6-bisphosphate and the bifunctional hormones. Liver ces are freey permeabe to gucose in either enzyme PFK-2/F-2,6-Pase (6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase). (F-1,6-Pase, fructose 1,6-bisphosphatase; PFK-1, irection (via the GLUT 2 transporter), whereas ces of extra- phosphofructokinase-1 [6-phosphofructo-1-kinase].) Arrows with hepatic tissues (apart from pancreatic β-isets) are reativey wavy shafts indicate allosteric effects. impermeabe, an their uniirectiona gucose transporters are reguate by insuin. As a resut, uptake from the boo- can be toerate if hypogycemia eveops sowy enough for stream is an important, but not rate imiting uner a settings, aaptation to occur. The boo gucose eve in birs is con- (see Chapter 14) eterminant of the utiization of gucose in sieraby higher (14 mmo/L) an in ruminants consieraby extrahepatic tissues. The roe of various gucose transporter ower (~2.2 mmo/L in sheep an 3.3 mmo/L in catte). These proteins foun in ce membranes is shown in Table 19–2. ower norma eves appear to be associate with the fact that ruminants ferment virtuay ietary carbohyrate to short- Glucokinase Is Important in Regulating chain fatty acis, an these argey repace gucose as the main metaboic fue of the tissues in the fe state. Blood Glucose After a Meal Hexokinase has a ow Km for gucose, an in the iver it is satu- rate with ow capacity an acting at a constant rate uner a BLOOD GLUCOSE IS norma conitions. It thus acts to ensure an aequate rate of DERIVED FROM THE DIET, gycoysis to meet the iver’s nees. Gucokinase is an aosteric GLUCONEOGENESIS, & enzyme with a consieraby higher apparent Km (ower affinity) for gucose, so that its activity increases with increase in the con- GLYCOGENOLYSIS centration of gucose in the hepatic porta vein (Figure 19–6). The igestibe ietary carbohyrates yie gucose, gaactose, In the fasting state, gucokinase is ocate in the nuceus. In an fructose that are transporte to the iver via the hepatic response to an increase intraceuar concentration of gu- portal vein. Gaactose an fructose are reaiy converte to cose it migrates into the cytoso, meiate by the carbohyrate gucose in the iver (see Chapter 20). response eement-bining protein (CREBP). It permits hepatic CHAPTER 19 Gluconeogenesis & the Control of Blood Glucose 187 Blood Glucose Liver Muscle Glucose-6-phosphate Glycogen Glycogen Glucose-6-phosphate Urea Pyruvate Lactate Lactate Pyruvate Tra –NH2 n –NH2 tio ns Lactate na am mi ina a Blood ns tio Tra n Pyruvate Alanine Alanine Alanine FIGURE 19–5 The lactic acid (Cori cycle) and glucose-alanine cycles. uptake of arge amounts of gucose after a carbohyrate mea, is prouce by the β ces of the isets of Langerhans in the for gycogen an fatty aci synthesis. Whie the concentration pancreas in response to hypergycemia. The β-iset ces are of gucose in the hepatic porta vein may reach 20 mmo/L after freey permeabe to gucose via the GLUT 2 transporter, a mea, that eaving the iver into the periphera circuation oes an the gucose is phosphoryate by gucokinase. There- not normay excee 8 to 9 mmo/L. Gucokinase is absent from fore, increasing boo gucose increases metaboic fux the iver of ruminants, which have itte gucose entering the through gycoysis, the citric aci cyce, an the genera- porta circuation from the intestines. tion of ATP. The increase in [ATP] inhibits ATP-sensitive At norma periphera boo gucose concentrations K+ channes, causing epoarization of the ce membrane, (4.5-5.5 mmo/L), the iver is a net proucer of gucose. How- which increases Ca2+ infux via votage-sensitive Ca2+ chan- ever, as the gucose eve rises, the output of gucose ceases, nes, stimuating exocytosis of insuin. Thus, the concen- an there is a net uptake (see Figure 14–1). tration of insuin in the boo paraes that of the boo gucose. Other substances causing reease of insuin from the pancreas incue amino acis, nonesterifie fatty acis, Insulin & Glucagon Play a Central Role ketone boies, gucagon, secretin, an the sufonyurea in Regulating Blood Glucose rugs tobutamie an gyburie. These rugs are use In aition to the irect effects of hypergycemia in to stimuate insuin secretion in Type 2 iabetes meitus enhancing the uptake of gucose into the iver, the hormone via the ATP-sensitive K+ channes. Drugs that augment insulin pays a centra roe in reguating boo gucose. It gucagon-ike-peptie signas increase cycic-AMP, which TABLE 19–2 Major Glucose Transporters Tissue Location Functions Facilitative bidirectional transporters GLUT 1 Brain, kidney, colon, placenta, erythrocytes Glucose uptake GLUT 2 Liver, pancreatic β cell, small intestine, kidney Rapid uptake or release of glucose GLUT 3 Brain, kidney, placenta Glucose uptake GLUT 4 Heart and skeletal muscle, adipose tissue Insulin-stimulated glucose uptake GLUT 5 Small intestine Absorption of fructose Sodium-dependent unidirectional transporter SGLT 1 Small intestine and kidney Active uptake of glucose against a concentration gradient 188 SECTION IV Metabolism of Carbohydrates Vmax 100 Hexokinase Tabe 19–1). Both hepatic gycogenoysis an guconeogen- esis contribute to the hyperglycemic effect of gucagon, whose actions oppose those of insuin. Most of the enog- enous gucagon (an insuin) is ceare from the circuation by the iver (Table 19–3). Activity 50 Glucokinase Other Hormones Affect Blood Glucose The anterior pituitary gland secretes hormones that ten to eevate boo gucose an therefore antagonize the action of 0 5 10 15 20 25 insuin. These are growth hormone, arenocorticotropic hor- Blood glucose (mmol/L) mone (ACTH), an possiby other “iabetogenic” hormones. Growth hormone secretion is stimuate by hypogycemia; it FIGURE 19–6 Variation in glucose phosphorylating activity ecreases gucose uptake in musce. Some of this effect may of hexokinase and glucokinase with increasing blood glucose concentration. The Km for glucose of hexokinase is 0.05 mmol/L and be inirect, since it stimuates mobiization of nonesterifie of glucokinase is 10 mmol/L. fatty acis from aipose tissue, which themseves inhibit gu- cose utiization. The glucocorticoids (11-oxysterois) are secrete by the arena cortex, an are aso synthesize in an potentiate gucose-stimuate insuin secretion. Epineph- unreguate manner in aipose tissue. They act to increase rine an norepinephrine bock the reease of insuin. Insu- guconeogenesis as a resut of enhance hepatic cataboism in acts to ower boo gucose immeiatey by enhancing of amino acis, ue to inuction of aminotransferases (an gucose transport into aipose tissue an musce by recruit- other enzymes such as tryptophan ioxygenase) an key ment of gucose transporters (GLUT 4) from the interior enzymes of guconeogenesis. In aition, gucocorticois of the ce to the pasma membrane. Athough it oes not inhibit the utiization of gucose in extrahepatic tissues. In a affect gucose transport activity in the iver, it irecty aug- these actions, gucocorticois act in a manner antagonistic ments iver gucose uptake an gycogen eposition ikey to insuin. A number of cytokines secrete by macrophages through effects on gucokinase an gycogen synthase an infitrating aipose tissue aso have insuin antagonistic phosphoryase activity. Insuin an other hormones mou- actions; together with gucocorticois secrete by aipose ate ong-term uptake as a resut of their actions on tran- tissue, this expains the insuin resistance that commony scriptiona signas to change an entire enzyme portfoio occurs in obese peope. controing gycoysis, gycogenesis, an guconeogenesis Epinephrine is secrete by the arena meua because (see Chapter 18 an Tabe 19–1). of stressfu stimui (fear, excitement, hemorrhage, hypoxia, Glucagon is the hormone prouce by the α ces of hypogycemia, etc.) an eas to gycogenoysis in iver an the pancreatic isets in response to hypogycemia. In the musce owing to stimuation of phosphoryase via generation iver, it stimuates gycogenoysis by activating gycogen of cAMP. In musce, gycogenoysis resuts in increase gyco- phosphoryase. Unike epinephrine, gucagon oes not ysis an actate reease, whereas in iver, it resuts in the reease have an effect on musce phosphoryase. Gucagon aso of gucose into the boostream. Epinephrine is a potent stim- enhances guconeogenesis from amino acis an actate. In uator of guconeogenesis because of the robust increase in a these actions, gucagon acts via generation of cAMP (see substrate suppy. TABLE 19–3 Tissue Responses to Insulin & Glucagon Liver Adipose Tissue Muscle Increased by insulin Fatty acid synthesis Glucose uptake Glucose uptake Glycogen synthesis Fatty acid synthesis Glycogen synthesis Protein synthesis Protein synthesis Fatty acid synthesis Decreased by insulin Ketogenesis Lipolysis Gluconeogenesis Increased by glucagon Glycogenolysis Lipolysis Gluconeogenesis Ketogenesis CHAPTER 19 Gluconeogenesis & the Control of Blood Glucose 189 FURTHER CLINICAL ASPECTS which wou normay be reease from aipose tissue, is avaiabe for guconeogenesis. Glucosuria Occurs When the Renal Threshold for Glucose Is Exceeded The Ability to Utilize Glucose May Be When the boo gucose concentration rises above about Ascertained by Measuring Glucose 10 mmo/L, the kiney aso exerts a (passive) reguatory effect. Gucose is continuousy fitere by the gomerui, but is nor- Tolerance may competey reabsorbe in the rena tubues by active Gucose toerance is the abiity to reguate the boo gucose transport. The capacity of the tubuar system to reabsorb gu- concentration after the aministration of a test ose of gucose cose is imite to a rate of about 2 mmo/min, an in hyper- (normay 1 g/kg boy weight) (Figure 19–7). The norma gycemia (as occurs in poory controe iabetes meitus), gucose toerance is etermine by the timing of an quan- the gomeruar fitrate may contain more gucose than can be tity of insuin secrete an the abiity of tissues to respon to reabsorbe, resuting in glucosuria when the renal threshold insuin. If a person gains weight, they become insuin resistant. for gucose is exceee. Thus a common cinica presentation Most peope who gain weight o not become gucose intoer- of iabetes is unexpaine weight oss an frequent urina- ant because their beta ces compensate an make aitiona tion. The weight oss is ue to the voume oss an subsequent insuin to maintain norma gucose toerance. However, their ehyration ue to osmotic iuresis in the kiney combine risk of eveoping iabetes increases. Cinicay, the gucose with the oss of gucose caories in the urine. toerance test is primariy use to etect gestationa iabetes. To etermine average boo gucose in a person cinicians measure gycosyation status (see Chapter 15) of hemogobin Hypoglycemia May Occur During (HbA1c), which correates with the person’s average gucose Pregnancy & in the Neonate over a 2 to 3 month perio. If it is (norma 6.5%) more than 6.5%, it is iagnostic of there is a risk of materna, an possiby feta, hypogyce- iabetes. mia, particuary if there are ong intervas between meas Diabetes mellitus (type 1, or insuin-epenent ia- or at night. Furthermore, premature an ow-birth-weight betes meitus [IDDM]) is characterize by impaire gu- babies are more susceptibe to hypogycemia, since they have cose toerance as a resut of ecrease secretion of insuin itte aipose tissue to provie nonesterifie fatty acis. The because of progressive estruction of pancreatic β-iset ces. enzymes of guconeogenesis may not be fuy eveope at this Gucose toerance is aso impaire in Type 2 iabetes mei- time, an guconeogenesis is anyway epenent on a suppy tus (noninsuin-epenent iabetes [NIDDM]) as a resut of of nonesterifie fatty acis for ATP formation. Litte gycero, reuce sensitivity of tissues to insuin action combine with 18 16 14 Plasma glucose (mmol /L) 12 10 Diabetic 8 6 4 Normal 2 0 0 1 2 3 Time after glucose load (h) FIGURE 19–7 Glucose tolerance test. Blood glucose curves of a normal and a diabetic person after oral administration of 1 g of glucose/kg body weight. Note the initial raised concentration in the fasting diabetic (>7 mM); so by definition they are diabetic without measuring glucose tolerance. If baseline glucose is in the normal range, a criterion of normal tolerance is the return to the baseline value within 2 hours. 190 SECTION IV Metabolism of Carbohydrates an impaire secretion of insuin. Insuin resistance associate met by oxiation of fatty acis. Whie this is ogica, controe with obesity (an especiay abomina obesity) eaing to the energy baance stuies emonstrate that energy expeniture is eveopment of hyperipiemia, then atheroscerosis an cor- in fact not increase. In the en a caorie is a caorie. Weight oss onary heart isease, as we as overt iabetes, is known as the occurs because they eat ess caories. The rapi weight oss com- metabolic syndrome. Impaire gucose toerance aso occurs mony seem with these iets is most ikey ue to the fact that in conitions where the iver is amage, in some infections, ow carbohyrate iets ecrease gycogen stores, which have 3 g an in response to some rugs, as we as in conitions that of water per gram of gycogen. The biggest chaenge is that stay- ea to hyperactivity of the pituitary gan or arena cortex ing on these or other extreme iets is neary impossibe. because hormones secrete by these gans antagonize the action of insuin. SUMMARY Aministration of insuin (as in the treatment of iabetes Guconeogenesis is the process of synthesizing gucose or meitus) owers the boo gucose concentration an increases gycogen from noncarbohyrate precursors. It is of particuar its utiization an storage in the iver an musce as gycogen. importance when carbohyrate is not avaiabe from the iet. An excess of insuin may cause hypoglycemia, resuting in The main substrates are amino acis, actate, gycero, an convusions an even eath uness gucose is aministere propionate. prompty. Hypogycemia upon fasting can be observe in The pathway of guconeogenesis in the iver an kiney pituitary or arenocortica insufficiency. It is ue to a ecrease utiizes those reactions in gycoysis that are reversibe pus in the antagonism to insuin an the ower guconeogenic four aitiona reactions that circumvent the irreversibe capacity of the iver. nonequiibrium reactions. Since gycoysis an guconeogenesis share the same pathway Think Otherwise: Very Low but operate in opposite irections, their activities are reguate Carbohydrate Diets Promote reciprocay. The iver reguates the boo gucose concentration after Weight Loss a mea because it contains the high Km gucokinase that Very ow carbohyrate iets, proviing ony 20 g per ay of promotes increase hepatic utiization of gucose an is carbohyrate or ess (compare with a esirabe intake of responsive to insuin. 100-120 g/ay), but permitting unimite consumption of fat Insuin is secrete as a irect response to hypergycemia; it an protein, have been promote as an effective regime for stimuates the iver to store gucose as gycogen an increases weight oss. Such iets are counter to a avice on a pruent iet uptake of gucose into extrahepatic tissues. composition for heath. Since there is a continua eman for Gucagon is secrete as a response to hypogycemia an gucose, there wi be a consierabe amount of guconeogenesis activates both gycogenoysis an guconeogenesis in the iver, from amino acis; the associate high ATP cost must then be causing reease of gucose into the boo.

Use Quizgecko on...
Browser
Browser